Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II)

Research output

Research output per year 2023 2023 2023

• 91 Citations
• 1 Article

Research output per year

Research output per year

Search results

• 2023

  Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-I)

  Morand, E. F., Vital, E. M., Petri, M., van Vollenhoven, R., Wallace, D. J., Mosca, M., Furie, R. A., Silk, M. E., Dickson, C. L., Meszaros, G., Jia, B., Crowe, B., de la Torre, I. & Dörner, T., 25 Mar 2023, In: The Lancet. 401, 10381, p. 1001-1010 10 p.

  Research output: Contribution to journal › Article › Research › peer-review
  83 Citations (Scopus)